| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $2.13 (Beat by $0.2) |
| EPS GAAP Actual | $2.13 (Beat by $0.2) |
| Revenue Actual | $3.017B |
| Revenue Surprise | Beat by $3017M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 8.5148 | 33.19 | 7.61294 | 9.37442 | 1 |
| Jun 2030 | 8.5148 | 33.19 | 7.67651 | 9.449 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | -3.34 | -3.34 | 3.017B | 23.96% | 3017M |
| FQ4 2025 (Oct 2025) | 3.34 | 3.34 | 2.818B | -52.06% | 2818M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 2.605B | -44.49% | 2605M |
| FQ1 2025 (Mar 2025) | 1.54 | 1.54 | 2.294B | -50.7% | 2294M |
| FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 4.285B | 29.24% | 4285M |
| FQ3 2024 (Sep 2024) | 1.4 | 1.4 | 4.095B | 32.84% | 4095M |
| FQ2 2024 (Jun 2024) | 0.92 | 0.92 | 3.764B | 29.01% | 3764M |
| FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 3.457B | 18.92% | 3457M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Jul 2028) | 4.2097 | -- | 4.03915 | 4.31874 | 5 |
| FQ2 2028 (Apr 2028) | 4.21396 | -- | 4.04324 | 4.32311 | 5 |
| FQ1 2028 (Jan 2028) | 4.28811 | -- | 4.11438 | 4.39918 | 5 |
| FQ4 2027 (Oct 2027) | 4.01634 | -- | 3.85362 | 4.12038 | 4 |
| FQ3 2027 (Jul 2027) | 2.33294 | -- | 2.11317 | 2.43048 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Jul 2028) | 4.52B | -- | 4.38B | 4.61B | 4 |
| FQ2 2028 (Apr 2028) | 4.51B | -- | 4.37B | 4.6B | 4 |
| FQ1 2028 (Jan 2028) | 4.55B | -- | 4.41B | 4.65B | 4 |
| FQ4 2027 (Oct 2027) | 4.39B | -- | 4.25B | 4.47B | 5 |
| FQ3 2027 (Jul 2027) | 3.24B | -- | 3.01B | 3.35B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | -3.34 | -3.34 | 100% | |
| FQ4 2025 (Oct 2025) | 3.34 | 3.34 | 100% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | 1.54 | 1.54 | 100% | |
| FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 100% | |
| FQ3 2024 (Sep 2024) | 1.4 | 1.4 | 100% | |
| FQ2 2024 (Jun 2024) | 0.92 | 0.92 | 100% | |
| FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | $0B | $3.02B | $3017M | 100% |
| FQ4 2025 (Oct 2025) | $0B | $2.82B | $2818M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.61B | $2605M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.29B | $2294M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4.29B | $4285M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.1B | $4095M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.76B | $3764M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.46B | $3457M | 100% |